Market Movers Today: Acxiom Corporation (ACXM), GameStop Corp. (GME), Galectin Therapeutics Inc. (GALT), Verint Systems Inc. (VRNT), and More

Movado Group, Inc (NYSE:MOV) (The Motley Fool)
What happened: Shares of Movado Group Inc. (NYSE:MOV) were up 15.8% as of 1 p.m. EDT Thursday, after the Swiss watchmaker announced stronger-than-expected fiscal fourth-quarter 2018 results and boosted its dividend. Movado’s quarterly revenue grew 14.1% year over year (or 10.2% at constant currencies) to $149.2 million, well above the $132.5 million investors were expecting.

PVH Corp (NYSE:PVH) (CNBC)
PVH – PVH reported adjusted quarterly profit of $1.58 per share, 11 cents a share ahead of consensus forecasts. Revenue also beat estimates and the apparel maker gave upbeat 2018 guidance as sales of its Tommy Hilfiger and Calvin Klein brands remain strong.

MediciNova, Inc. (NASDAQ:MNOV) (Benzinga)
MediciNova, Inc. declined 13.3 percent to $10.37 after the company disclosed that its Phase 2 clinical trial of MN-166 did not meet primary endpoint.

Constellation Brands, Inc. (NYSE:STZ) (MarketWatch)
Shares of Constellation Brands Inc. STZ, +3.73% shot up 3.4% in premarket trade Thursday, after the alcoholic beverage company reported fiscal fourth-quarter profit and sales that beat expectations, and boosted its dividend by 42%. Net income for the quarter to Feb. 28 rose to $925.5 million, or $4.64 a share, from $452.0 million, or $2.26 a share, in the same period a year ago.

Takeda Pharmaceutical Co Ltd (ADR) (OTCMKTS:TKPYY) (The Wall Street Journal)
TOKYO- Takeda Pharmaceutical Co. TKPYY -4.94% shares fell 7.4% on Thursday to their lowest level in more than a year, over concerns that the potential of a blockbuster deal to acquire Shire PLC was too much for the Japanese company to swallow. Takeda said Wednesday it was weighing a bid for Western rival Shire, raising the prospect of a combination that would create a global top-10 drug maker with a market value of more than $80 billion. It called the study “exploratory” and said it would decide by April 25 whether to go through with such a bid.